nodes	percent_of_prediction	percent_of_DWPC	metapath
Octreotide—thymus cancer—germ cell cancer	0.784	1	CtDrD
Octreotide—MPO—Cisplatin—germ cell cancer	0.0881	1	CbGbCtD
Octreotide—SSTR4—telencephalon—germ cell cancer	0.00232	0.0526	CbGeAlD
Octreotide—SSTR5—brainstem—germ cell cancer	0.00223	0.0504	CbGeAlD
Octreotide—SSTR3—brainstem—germ cell cancer	0.00213	0.0483	CbGeAlD
Octreotide—SSTR1—brainstem—germ cell cancer	0.00169	0.0382	CbGeAlD
Octreotide—SSTR5—pituitary gland—germ cell cancer	0.00161	0.0364	CbGeAlD
Octreotide—SSTR4—female gonad—germ cell cancer	0.00158	0.0357	CbGeAlD
Octreotide—SSTR3—pituitary gland—germ cell cancer	0.00154	0.0349	CbGeAlD
Octreotide—SSTR1—telencephalon—germ cell cancer	0.0015	0.0339	CbGeAlD
Octreotide—SSTR4—endocrine gland—germ cell cancer	0.00147	0.0332	CbGeAlD
Octreotide—SSTR4—head—germ cell cancer	0.00145	0.0328	CbGeAlD
Octreotide—SSTR2—brainstem—germ cell cancer	0.00143	0.0325	CbGeAlD
Octreotide—SSTR2—eye—germ cell cancer	0.0014	0.0316	CbGeAlD
Octreotide—SSTR2—telencephalon—germ cell cancer	0.00127	0.0288	CbGeAlD
Octreotide—SSTR5—endocrine gland—germ cell cancer	0.00125	0.0282	CbGeAlD
Octreotide—SSTR1—pituitary gland—germ cell cancer	0.00122	0.0276	CbGeAlD
Octreotide—SSTR3—endocrine gland—germ cell cancer	0.00119	0.0271	CbGeAlD
Octreotide—SSTR3—head—germ cell cancer	0.00118	0.0267	CbGeAlD
Octreotide—SSTR5—cerebellum—germ cell cancer	0.0011	0.0249	CbGeAlD
Octreotide—MPO—endothelium—germ cell cancer	0.00108	0.0244	CbGeAlD
Octreotide—SSTR1—midbrain—germ cell cancer	0.00108	0.0244	CbGeAlD
Octreotide—SSTR3—cerebellum—germ cell cancer	0.00105	0.0238	CbGeAlD
Octreotide—SSTR4—brain—germ cell cancer	0.00105	0.0237	CbGeAlD
Octreotide—SSTR2—pituitary gland—germ cell cancer	0.00104	0.0235	CbGeAlD
Octreotide—MPO—blood vessel—germ cell cancer	0.000994	0.0225	CbGeAlD
Octreotide—SSTR1—endocrine gland—germ cell cancer	0.000944	0.0214	CbGeAlD
Octreotide—SSTR1—head—germ cell cancer	0.000932	0.0211	CbGeAlD
Octreotide—SSTR3—brain—germ cell cancer	0.000855	0.0194	CbGeAlD
Octreotide—SSTR1—cerebellum—germ cell cancer	0.000832	0.0188	CbGeAlD
Octreotide—SSTR1—SIDS Susceptibility Pathways—NANOG—germ cell cancer	0.000825	0.0576	CbGpPWpGaD
Octreotide—SSTR2—endocrine gland—germ cell cancer	0.000803	0.0182	CbGeAlD
Octreotide—SSTR1—SIDS Susceptibility Pathways—POU5F1—germ cell cancer	0.000794	0.0555	CbGpPWpGaD
Octreotide—SSTR2—head—germ cell cancer	0.000793	0.018	CbGeAlD
Octreotide—SSTR2—cerebellum—germ cell cancer	0.000707	0.016	CbGeAlD
Octreotide—SSTR1—brain—germ cell cancer	0.000676	0.0153	CbGeAlD
Octreotide—SSTR2—SIDS Susceptibility Pathways—NANOG—germ cell cancer	0.000675	0.0472	CbGpPWpGaD
Octreotide—SSTR2—SIDS Susceptibility Pathways—POU5F1—germ cell cancer	0.00065	0.0454	CbGpPWpGaD
Octreotide—SSTR2—brain—germ cell cancer	0.000574	0.013	CbGeAlD
Octreotide—MPO—skin of body—germ cell cancer	0.00046	0.0104	CbGeAlD
Octreotide—SSTR4—Peptide ligand-binding receptors—OXT—germ cell cancer	0.000445	0.0311	CbGpPWpGaD
Octreotide—SSTR1—SIDS Susceptibility Pathways—SOX2—germ cell cancer	0.00044	0.0308	CbGpPWpGaD
Octreotide—MPO—pituitary gland—germ cell cancer	0.000392	0.00889	CbGeAlD
Octreotide—SSTR2—SIDS Susceptibility Pathways—SOX2—germ cell cancer	0.00036	0.0252	CbGpPWpGaD
Octreotide—MPO—adrenal gland—germ cell cancer	0.000351	0.00794	CbGeAlD
Octreotide—MPO—bone marrow—germ cell cancer	0.000339	0.00768	CbGeAlD
Octreotide—MPO—spinal cord—germ cell cancer	0.000338	0.00765	CbGeAlD
Octreotide—SSTR3—Peptide ligand-binding receptors—OXT—germ cell cancer	0.000337	0.0236	CbGpPWpGaD
Octreotide—SSTR1—Peptide ligand-binding receptors—OXT—germ cell cancer	0.000323	0.0226	CbGpPWpGaD
Octreotide—SSTR4—Peptide ligand-binding receptors—AVP—germ cell cancer	0.000305	0.0213	CbGpPWpGaD
Octreotide—MPO—endocrine gland—germ cell cancer	0.000304	0.00689	CbGeAlD
Octreotide—MPO—head—germ cell cancer	0.0003	0.0068	CbGeAlD
Octreotide—SSTR4—Class A/1 (Rhodopsin-like receptors)—OXT—germ cell cancer	0.000299	0.0209	CbGpPWpGaD
Octreotide—MPO—testis—germ cell cancer	0.00029	0.00657	CbGeAlD
Octreotide—SSTR5—Peptide ligand-binding receptors—OXT—germ cell cancer	0.000287	0.02	CbGpPWpGaD
Octreotide—SSTR2—Peptide ligand-binding receptors—OXT—germ cell cancer	0.000265	0.0185	CbGpPWpGaD
Octreotide—SSTR1—SIDS Susceptibility Pathways—AVP—germ cell cancer	0.00026	0.0181	CbGpPWpGaD
Octreotide—MPO—C-MYB transcription factor network—H2AFZ—germ cell cancer	0.00026	0.0181	CbGpPWpGaD
Octreotide—MPO—C-MYB transcription factor network—KITLG—germ cell cancer	0.000239	0.0167	CbGpPWpGaD
Octreotide—SSTR3—Peptide ligand-binding receptors—AVP—germ cell cancer	0.000231	0.0162	CbGpPWpGaD
Octreotide—SSTR4—GPCR ligand binding—OXT—germ cell cancer	0.000227	0.0159	CbGpPWpGaD
Octreotide—SSTR3—Class A/1 (Rhodopsin-like receptors)—OXT—germ cell cancer	0.000226	0.0158	CbGpPWpGaD
Octreotide—SSTR1—Peptide ligand-binding receptors—AVP—germ cell cancer	0.000222	0.0155	CbGpPWpGaD
Octreotide—MPO—brain—germ cell cancer	0.000218	0.00493	CbGeAlD
Octreotide—SSTR1—Class A/1 (Rhodopsin-like receptors)—OXT—germ cell cancer	0.000217	0.0152	CbGpPWpGaD
Octreotide—SSTR2—SIDS Susceptibility Pathways—AVP—germ cell cancer	0.000212	0.0148	CbGpPWpGaD
Octreotide—MPO—lymph node—germ cell cancer	0.00021	0.00476	CbGeAlD
Octreotide—SSTR4—Class A/1 (Rhodopsin-like receptors)—AVP—germ cell cancer	0.000205	0.0143	CbGpPWpGaD
Octreotide—SSTR5—Peptide ligand-binding receptors—AVP—germ cell cancer	0.000197	0.0137	CbGpPWpGaD
Octreotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—OXT—germ cell cancer	0.000192	0.0134	CbGpPWpGaD
Octreotide—SSTR2—Peptide ligand-binding receptors—AVP—germ cell cancer	0.000181	0.0127	CbGpPWpGaD
Octreotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—OXT—germ cell cancer	0.000178	0.0124	CbGpPWpGaD
Octreotide—SSTR3—GPCR ligand binding—OXT—germ cell cancer	0.000172	0.012	CbGpPWpGaD
Octreotide—SSTR1—GPCR ligand binding—OXT—germ cell cancer	0.000165	0.0115	CbGpPWpGaD
Octreotide—MPO—C-MYB transcription factor network—KIT—germ cell cancer	0.000163	0.0114	CbGpPWpGaD
Octreotide—SSTR4—GPCR ligand binding—AVP—germ cell cancer	0.000156	0.0109	CbGpPWpGaD
Octreotide—SSTR3—Class A/1 (Rhodopsin-like receptors)—AVP—germ cell cancer	0.000155	0.0108	CbGpPWpGaD
Octreotide—SSTR1—Class A/1 (Rhodopsin-like receptors)—AVP—germ cell cancer	0.000149	0.0104	CbGpPWpGaD
Octreotide—SSTR5—GPCR ligand binding—OXT—germ cell cancer	0.000147	0.0102	CbGpPWpGaD
Octreotide—SSTR2—GPCR ligand binding—OXT—germ cell cancer	0.000135	0.00945	CbGpPWpGaD
Octreotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—AVP—germ cell cancer	0.000132	0.00922	CbGpPWpGaD
Octreotide—SSTR4—GPCR downstream signaling—OXT—germ cell cancer	0.000128	0.00898	CbGpPWpGaD
Octreotide—Cardiac disorder—Cisplatin—germ cell cancer	0.000122	0.00175	CcSEcCtD
Octreotide—Agitation—Ifosfamide—germ cell cancer	0.000122	0.00175	CcSEcCtD
Octreotide—Discomfort—Dactinomycin—germ cell cancer	0.000122	0.00175	CcSEcCtD
Octreotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—AVP—germ cell cancer	0.000122	0.0085	CbGpPWpGaD
Octreotide—Anorexia—Bleomycin—germ cell cancer	0.000121	0.00173	CcSEcCtD
Octreotide—Thrombophlebitis—Methotrexate—germ cell cancer	0.00012	0.00173	CcSEcCtD
Octreotide—Diabetes mellitus—Methotrexate—germ cell cancer	0.00012	0.00172	CcSEcCtD
Octreotide—Hypoaesthesia—Etoposide—germ cell cancer	0.00012	0.00172	CcSEcCtD
Octreotide—Malaise—Ifosfamide—germ cell cancer	0.00012	0.00172	CcSEcCtD
Octreotide—Vertigo—Ifosfamide—germ cell cancer	0.000119	0.00171	CcSEcCtD
Octreotide—Polyuria—Methotrexate—germ cell cancer	0.000119	0.00171	CcSEcCtD
Octreotide—Immune system disorder—Cisplatin—germ cell cancer	0.000119	0.0017	CcSEcCtD
Octreotide—Abdominal pain—Vinblastine—germ cell cancer	0.000119	0.0017	CcSEcCtD
Octreotide—Oedema—Dactinomycin—germ cell cancer	0.000118	0.0017	CcSEcCtD
Octreotide—SSTR3—GPCR ligand binding—AVP—germ cell cancer	0.000118	0.00825	CbGpPWpGaD
Octreotide—Infection—Dactinomycin—germ cell cancer	0.000117	0.00169	CcSEcCtD
Octreotide—Arrhythmia—Cisplatin—germ cell cancer	0.000117	0.00169	CcSEcCtD
Octreotide—Palpitations—Ifosfamide—germ cell cancer	0.000117	0.00168	CcSEcCtD
Octreotide—SSTR4—Signaling by GPCR—OXT—germ cell cancer	0.000117	0.00815	CbGpPWpGaD
Octreotide—Alopecia—Cisplatin—germ cell cancer	0.000116	0.00167	CcSEcCtD
Octreotide—Cough—Ifosfamide—germ cell cancer	0.000116	0.00166	CcSEcCtD
Octreotide—Thrombocytopenia—Dactinomycin—germ cell cancer	0.000116	0.00166	CcSEcCtD
Octreotide—Musculoskeletal discomfort—Bleomycin—germ cell cancer	0.000115	0.00166	CcSEcCtD
Octreotide—Convulsion—Ifosfamide—germ cell cancer	0.000115	0.00165	CcSEcCtD
Octreotide—Hypertension—Ifosfamide—germ cell cancer	0.000115	0.00165	CcSEcCtD
Octreotide—Erythema—Cisplatin—germ cell cancer	0.000114	0.00164	CcSEcCtD
Octreotide—Malnutrition—Cisplatin—germ cell cancer	0.000114	0.00164	CcSEcCtD
Octreotide—Paraesthesia—Bleomycin—germ cell cancer	0.000114	0.00163	CcSEcCtD
Octreotide—SSTR1—GPCR ligand binding—AVP—germ cell cancer	0.000113	0.00791	CbGpPWpGaD
Octreotide—Dyspnoea—Bleomycin—germ cell cancer	0.000113	0.00162	CcSEcCtD
Octreotide—Myalgia—Ifosfamide—germ cell cancer	0.000113	0.00162	CcSEcCtD
Octreotide—Chest pain—Ifosfamide—germ cell cancer	0.000113	0.00162	CcSEcCtD
Octreotide—Arthralgia—Ifosfamide—germ cell cancer	0.000113	0.00162	CcSEcCtD
Octreotide—Flatulence—Cisplatin—germ cell cancer	0.000113	0.00162	CcSEcCtD
Octreotide—Anorexia—Dactinomycin—germ cell cancer	0.000113	0.00162	CcSEcCtD
Octreotide—Unspecified disorder of skin and subcutaneous tissue—Ifosfamide—germ cell cancer	0.000112	0.00161	CcSEcCtD
Octreotide—Flushing—Etoposide—germ cell cancer	0.000112	0.0016	CcSEcCtD
Octreotide—Cardiac disorder—Etoposide—germ cell cancer	0.000112	0.0016	CcSEcCtD
Octreotide—Discomfort—Ifosfamide—germ cell cancer	0.000112	0.0016	CcSEcCtD
Octreotide—Hypersensitivity—Vinblastine—germ cell cancer	0.000111	0.00159	CcSEcCtD
Octreotide—Decreased appetite—Bleomycin—germ cell cancer	0.00011	0.00158	CcSEcCtD
Octreotide—Visual disturbance—Methotrexate—germ cell cancer	0.00011	0.00158	CcSEcCtD
Octreotide—Muscle spasms—Cisplatin—germ cell cancer	0.00011	0.00158	CcSEcCtD
Octreotide—Immune system disorder—Etoposide—germ cell cancer	0.000109	0.00156	CcSEcCtD
Octreotide—Pain—Bleomycin—germ cell cancer	0.000108	0.00156	CcSEcCtD
Octreotide—Anaphylactic shock—Ifosfamide—germ cell cancer	0.000108	0.00156	CcSEcCtD
Octreotide—Oedema—Ifosfamide—germ cell cancer	0.000108	0.00156	CcSEcCtD
Octreotide—Vision blurred—Cisplatin—germ cell cancer	0.000108	0.00155	CcSEcCtD
Octreotide—Anaphylactoid reaction—Methotrexate—germ cell cancer	0.000108	0.00155	CcSEcCtD
Octreotide—Musculoskeletal discomfort—Dactinomycin—germ cell cancer	0.000108	0.00155	CcSEcCtD
Octreotide—Asthenia—Vinblastine—germ cell cancer	0.000108	0.00155	CcSEcCtD
Octreotide—Infection—Ifosfamide—germ cell cancer	0.000108	0.00155	CcSEcCtD
Octreotide—Tremor—Cisplatin—germ cell cancer	0.000107	0.00154	CcSEcCtD
Octreotide—Alopecia—Etoposide—germ cell cancer	0.000106	0.00153	CcSEcCtD
Octreotide—Nervous system disorder—Ifosfamide—germ cell cancer	0.000106	0.00153	CcSEcCtD
Octreotide—Ill-defined disorder—Cisplatin—germ cell cancer	0.000106	0.00152	CcSEcCtD
Octreotide—Thrombocytopenia—Ifosfamide—germ cell cancer	0.000106	0.00152	CcSEcCtD
Octreotide—Anaemia—Cisplatin—germ cell cancer	0.000106	0.00152	CcSEcCtD
Octreotide—Skin disorder—Ifosfamide—germ cell cancer	0.000105	0.00151	CcSEcCtD
Octreotide—Hyperhidrosis—Ifosfamide—germ cell cancer	0.000105	0.0015	CcSEcCtD
Octreotide—Feeling abnormal—Bleomycin—germ cell cancer	0.000104	0.0015	CcSEcCtD
Octreotide—Osteoarthritis—Methotrexate—germ cell cancer	0.000104	0.0015	CcSEcCtD
Octreotide—Anorexia—Ifosfamide—germ cell cancer	0.000103	0.00148	CcSEcCtD
Octreotide—Malaise—Cisplatin—germ cell cancer	0.000103	0.00148	CcSEcCtD
Octreotide—Decreased appetite—Dactinomycin—germ cell cancer	0.000103	0.00148	CcSEcCtD
Octreotide—Diarrhoea—Vinblastine—germ cell cancer	0.000103	0.00147	CcSEcCtD
Octreotide—Fatigue—Dactinomycin—germ cell cancer	0.000102	0.00146	CcSEcCtD
Octreotide—Back pain—Etoposide—germ cell cancer	0.000101	0.00146	CcSEcCtD
Octreotide—Pain—Dactinomycin—germ cell cancer	0.000101	0.00145	CcSEcCtD
Octreotide—Muscle spasms—Etoposide—germ cell cancer	0.000101	0.00145	CcSEcCtD
Octreotide—Urticaria—Bleomycin—germ cell cancer	0.000101	0.00145	CcSEcCtD
Octreotide—SSTR5—GPCR ligand binding—AVP—germ cell cancer	0.0001	0.00702	CbGpPWpGaD
Octreotide—Body temperature increased—Bleomycin—germ cell cancer	0.0001	0.00144	CcSEcCtD
Octreotide—Irritability—Methotrexate—germ cell cancer	9.95e-05	0.00143	CcSEcCtD
Octreotide—Dizziness—Vinblastine—germ cell cancer	9.92e-05	0.00143	CcSEcCtD
Octreotide—Convulsion—Cisplatin—germ cell cancer	9.92e-05	0.00142	CcSEcCtD
Octreotide—Musculoskeletal discomfort—Ifosfamide—germ cell cancer	9.87e-05	0.00142	CcSEcCtD
Octreotide—Myalgia—Cisplatin—germ cell cancer	9.74e-05	0.0014	CcSEcCtD
Octreotide—Feeling abnormal—Dactinomycin—germ cell cancer	9.74e-05	0.0014	CcSEcCtD
Octreotide—SSTR3—GPCR downstream signaling—OXT—germ cell cancer	9.74e-05	0.0068	CbGpPWpGaD
Octreotide—Paraesthesia—Ifosfamide—germ cell cancer	9.73e-05	0.0014	CcSEcCtD
Octreotide—Ill-defined disorder—Etoposide—germ cell cancer	9.73e-05	0.0014	CcSEcCtD
Octreotide—Anxiety—Cisplatin—germ cell cancer	9.71e-05	0.00139	CcSEcCtD
Octreotide—Anaemia—Etoposide—germ cell cancer	9.69e-05	0.00139	CcSEcCtD
Octreotide—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—germ cell cancer	9.68e-05	0.00139	CcSEcCtD
Octreotide—Gastrointestinal pain—Dactinomycin—germ cell cancer	9.67e-05	0.00139	CcSEcCtD
Octreotide—Dyspnoea—Ifosfamide—germ cell cancer	9.66e-05	0.00139	CcSEcCtD
Octreotide—Somnolence—Ifosfamide—germ cell cancer	9.63e-05	0.00138	CcSEcCtD
Octreotide—Discomfort—Cisplatin—germ cell cancer	9.63e-05	0.00138	CcSEcCtD
Octreotide—Vomiting—Vinblastine—germ cell cancer	9.54e-05	0.00137	CcSEcCtD
Octreotide—Malaise—Etoposide—germ cell cancer	9.45e-05	0.00136	CcSEcCtD
Octreotide—Vertigo—Etoposide—germ cell cancer	9.42e-05	0.00135	CcSEcCtD
Octreotide—Decreased appetite—Ifosfamide—germ cell cancer	9.42e-05	0.00135	CcSEcCtD
Octreotide—Headache—Vinblastine—germ cell cancer	9.4e-05	0.00135	CcSEcCtD
Octreotide—Gastrointestinal disorder—Ifosfamide—germ cell cancer	9.35e-05	0.00134	CcSEcCtD
Octreotide—Body temperature increased—Dactinomycin—germ cell cancer	9.35e-05	0.00134	CcSEcCtD
Octreotide—Abdominal pain—Dactinomycin—germ cell cancer	9.35e-05	0.00134	CcSEcCtD
Octreotide—Fatigue—Ifosfamide—germ cell cancer	9.34e-05	0.00134	CcSEcCtD
Octreotide—Oedema—Cisplatin—germ cell cancer	9.34e-05	0.00134	CcSEcCtD
Octreotide—Anaphylactic shock—Cisplatin—germ cell cancer	9.34e-05	0.00134	CcSEcCtD
Octreotide—Hypersensitivity—Bleomycin—germ cell cancer	9.34e-05	0.00134	CcSEcCtD
Octreotide—SSTR1—GPCR downstream signaling—OXT—germ cell cancer	9.34e-05	0.00652	CbGpPWpGaD
Octreotide—Infection—Cisplatin—germ cell cancer	9.28e-05	0.00133	CcSEcCtD
Octreotide—SSTR2—GPCR ligand binding—AVP—germ cell cancer	9.27e-05	0.00648	CbGpPWpGaD
Octreotide—Pain—Ifosfamide—germ cell cancer	9.26e-05	0.00133	CcSEcCtD
Octreotide—Constipation—Ifosfamide—germ cell cancer	9.26e-05	0.00133	CcSEcCtD
Octreotide—Loss of consciousness—Etoposide—germ cell cancer	9.21e-05	0.00132	CcSEcCtD
Octreotide—Nervous system disorder—Cisplatin—germ cell cancer	9.16e-05	0.00132	CcSEcCtD
Octreotide—Cough—Etoposide—germ cell cancer	9.15e-05	0.00131	CcSEcCtD
Octreotide—Thrombocytopenia—Cisplatin—germ cell cancer	9.14e-05	0.00131	CcSEcCtD
Octreotide—Tachycardia—Cisplatin—germ cell cancer	9.12e-05	0.00131	CcSEcCtD
Octreotide—Asthenia—Bleomycin—germ cell cancer	9.09e-05	0.00131	CcSEcCtD
Octreotide—Convulsion—Etoposide—germ cell cancer	9.08e-05	0.0013	CcSEcCtD
Octreotide—Skin disorder—Cisplatin—germ cell cancer	9.07e-05	0.0013	CcSEcCtD
Octreotide—Hypertension—Etoposide—germ cell cancer	9.05e-05	0.0013	CcSEcCtD
Octreotide—Hyperhidrosis—Cisplatin—germ cell cancer	9.03e-05	0.0013	CcSEcCtD
Octreotide—Asthma—Methotrexate—germ cell cancer	9.01e-05	0.00129	CcSEcCtD
Octreotide—Pruritus—Bleomycin—germ cell cancer	8.97e-05	0.00129	CcSEcCtD
Octreotide—MPO—C-MYB transcription factor network—MYC—germ cell cancer	8.96e-05	0.00626	CbGpPWpGaD
Octreotide—MPO—Folate Metabolism—TP53—germ cell cancer	8.93e-05	0.00624	CbGpPWpGaD
Octreotide—Feeling abnormal—Ifosfamide—germ cell cancer	8.93e-05	0.00128	CcSEcCtD
Octreotide—Chest pain—Etoposide—germ cell cancer	8.93e-05	0.00128	CcSEcCtD
Octreotide—Nausea—Vinblastine—germ cell cancer	8.91e-05	0.00128	CcSEcCtD
Octreotide—Anorexia—Cisplatin—germ cell cancer	8.9e-05	0.00128	CcSEcCtD
Octreotide—Unspecified disorder of skin and subcutaneous tissue—Etoposide—germ cell cancer	8.86e-05	0.00127	CcSEcCtD
Octreotide—Gastrointestinal pain—Ifosfamide—germ cell cancer	8.86e-05	0.00127	CcSEcCtD
Octreotide—SSTR3—Signaling by GPCR—OXT—germ cell cancer	8.84e-05	0.00618	CbGpPWpGaD
Octreotide—Pancreatitis—Methotrexate—germ cell cancer	8.84e-05	0.00127	CcSEcCtD
Octreotide—Discomfort—Etoposide—germ cell cancer	8.82e-05	0.00127	CcSEcCtD
Octreotide—SSTR4—GPCR downstream signaling—AVP—germ cell cancer	8.81e-05	0.00615	CbGpPWpGaD
Octreotide—Hypersensitivity—Dactinomycin—germ cell cancer	8.71e-05	0.00125	CcSEcCtD
Octreotide—Abdominal discomfort—Methotrexate—germ cell cancer	8.64e-05	0.00124	CcSEcCtD
Octreotide—Urticaria—Ifosfamide—germ cell cancer	8.61e-05	0.00124	CcSEcCtD
Octreotide—Body temperature increased—Ifosfamide—germ cell cancer	8.56e-05	0.00123	CcSEcCtD
Octreotide—Abdominal pain—Ifosfamide—germ cell cancer	8.56e-05	0.00123	CcSEcCtD
Octreotide—Anaphylactic shock—Etoposide—germ cell cancer	8.56e-05	0.00123	CcSEcCtD
Octreotide—Musculoskeletal discomfort—Cisplatin—germ cell cancer	8.51e-05	0.00122	CcSEcCtD
Octreotide—Infection—Etoposide—germ cell cancer	8.5e-05	0.00122	CcSEcCtD
Octreotide—Asthenia—Dactinomycin—germ cell cancer	8.48e-05	0.00122	CcSEcCtD
Octreotide—SSTR1—Signaling by GPCR—OXT—germ cell cancer	8.48e-05	0.00592	CbGpPWpGaD
Octreotide—Dysuria—Methotrexate—germ cell cancer	8.43e-05	0.00121	CcSEcCtD
Octreotide—Paraesthesia—Cisplatin—germ cell cancer	8.39e-05	0.0012	CcSEcCtD
Octreotide—Thrombocytopenia—Etoposide—germ cell cancer	8.38e-05	0.0012	CcSEcCtD
Octreotide—Upper respiratory tract infection—Methotrexate—germ cell cancer	8.38e-05	0.0012	CcSEcCtD
Octreotide—Tachycardia—Etoposide—germ cell cancer	8.35e-05	0.0012	CcSEcCtD
Octreotide—Dyspnoea—Cisplatin—germ cell cancer	8.33e-05	0.0012	CcSEcCtD
Octreotide—Skin disorder—Etoposide—germ cell cancer	8.31e-05	0.00119	CcSEcCtD
Octreotide—SSTR5—GPCR downstream signaling—OXT—germ cell cancer	8.28e-05	0.00579	CbGpPWpGaD
Octreotide—Hyperhidrosis—Etoposide—germ cell cancer	8.27e-05	0.00119	CcSEcCtD
Octreotide—Anorexia—Etoposide—germ cell cancer	8.16e-05	0.00117	CcSEcCtD
Octreotide—Decreased appetite—Cisplatin—germ cell cancer	8.12e-05	0.00117	CcSEcCtD
Octreotide—Diarrhoea—Dactinomycin—germ cell cancer	8.09e-05	0.00116	CcSEcCtD
Octreotide—Pneumonia—Methotrexate—germ cell cancer	8.08e-05	0.00116	CcSEcCtD
Octreotide—Gastrointestinal disorder—Cisplatin—germ cell cancer	8.06e-05	0.00116	CcSEcCtD
Octreotide—Vomiting—Bleomycin—germ cell cancer	8.06e-05	0.00116	CcSEcCtD
Octreotide—Drowsiness—Methotrexate—germ cell cancer	8.04e-05	0.00115	CcSEcCtD
Octreotide—Depression—Methotrexate—germ cell cancer	8.01e-05	0.00115	CcSEcCtD
Octreotide—SSTR4—Signaling by GPCR—AVP—germ cell cancer	8e-05	0.00559	CbGpPWpGaD
Octreotide—Rash—Bleomycin—germ cell cancer	7.99e-05	0.00115	CcSEcCtD
Octreotide—Pain—Cisplatin—germ cell cancer	7.99e-05	0.00115	CcSEcCtD
Octreotide—Dermatitis—Bleomycin—germ cell cancer	7.99e-05	0.00115	CcSEcCtD
Octreotide—Hypersensitivity—Ifosfamide—germ cell cancer	7.98e-05	0.00115	CcSEcCtD
Octreotide—Conjunctivitis—Methotrexate—germ cell cancer	7.81e-05	0.00112	CcSEcCtD
Octreotide—Asthenia—Ifosfamide—germ cell cancer	7.77e-05	0.00112	CcSEcCtD
Octreotide—Feeling abnormal—Cisplatin—germ cell cancer	7.7e-05	0.00111	CcSEcCtD
Octreotide—Paraesthesia—Etoposide—germ cell cancer	7.68e-05	0.0011	CcSEcCtD
Octreotide—Pruritus—Ifosfamide—germ cell cancer	7.66e-05	0.0011	CcSEcCtD
Octreotide—Haematuria—Methotrexate—germ cell cancer	7.66e-05	0.0011	CcSEcCtD
Octreotide—SSTR2—GPCR downstream signaling—OXT—germ cell cancer	7.64e-05	0.00534	CbGpPWpGaD
Octreotide—Dyspnoea—Etoposide—germ cell cancer	7.63e-05	0.0011	CcSEcCtD
Octreotide—Somnolence—Etoposide—germ cell cancer	7.61e-05	0.00109	CcSEcCtD
Octreotide—Hepatobiliary disease—Methotrexate—germ cell cancer	7.6e-05	0.00109	CcSEcCtD
Octreotide—Epistaxis—Methotrexate—germ cell cancer	7.58e-05	0.00109	CcSEcCtD
Octreotide—Nausea—Bleomycin—germ cell cancer	7.53e-05	0.00108	CcSEcCtD
Octreotide—SSTR5—Signaling by GPCR—OXT—germ cell cancer	7.52e-05	0.00525	CbGpPWpGaD
Octreotide—Vomiting—Dactinomycin—germ cell cancer	7.52e-05	0.00108	CcSEcCtD
Octreotide—Rash—Dactinomycin—germ cell cancer	7.45e-05	0.00107	CcSEcCtD
Octreotide—Decreased appetite—Etoposide—germ cell cancer	7.44e-05	0.00107	CcSEcCtD
Octreotide—Diarrhoea—Ifosfamide—germ cell cancer	7.41e-05	0.00106	CcSEcCtD
Octreotide—Gastrointestinal disorder—Etoposide—germ cell cancer	7.39e-05	0.00106	CcSEcCtD
Octreotide—Body temperature increased—Cisplatin—germ cell cancer	7.38e-05	0.00106	CcSEcCtD
Octreotide—Fatigue—Etoposide—germ cell cancer	7.38e-05	0.00106	CcSEcCtD
Octreotide—Constipation—Etoposide—germ cell cancer	7.32e-05	0.00105	CcSEcCtD
Octreotide—Pain—Etoposide—germ cell cancer	7.32e-05	0.00105	CcSEcCtD
Octreotide—Hepatitis—Methotrexate—germ cell cancer	7.21e-05	0.00104	CcSEcCtD
Octreotide—Dizziness—Ifosfamide—germ cell cancer	7.16e-05	0.00103	CcSEcCtD
Octreotide—Pharyngitis—Methotrexate—germ cell cancer	7.16e-05	0.00103	CcSEcCtD
Octreotide—Feeling abnormal—Etoposide—germ cell cancer	7.05e-05	0.00101	CcSEcCtD
Octreotide—MPO—C-MYB transcription factor network—HRAS—germ cell cancer	7.04e-05	0.00492	CbGpPWpGaD
Octreotide—Nausea—Dactinomycin—germ cell cancer	7.02e-05	0.00101	CcSEcCtD
Octreotide—Gastrointestinal pain—Etoposide—germ cell cancer	7e-05	0.001	CcSEcCtD
Octreotide—Visual impairment—Methotrexate—germ cell cancer	6.95e-05	0.000998	CcSEcCtD
Octreotide—SSTR2—Signaling by GPCR—OXT—germ cell cancer	6.94e-05	0.00485	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—OXT—germ cell cancer	6.89e-05	0.00482	CbGpPWpGaD
Octreotide—Vomiting—Ifosfamide—germ cell cancer	6.89e-05	0.000989	CcSEcCtD
Octreotide—Hypersensitivity—Cisplatin—germ cell cancer	6.88e-05	0.000988	CcSEcCtD
Octreotide—Rash—Ifosfamide—germ cell cancer	6.83e-05	0.000981	CcSEcCtD
Octreotide—Dermatitis—Ifosfamide—germ cell cancer	6.82e-05	0.00098	CcSEcCtD
Octreotide—Urticaria—Etoposide—germ cell cancer	6.8e-05	0.000976	CcSEcCtD
Octreotide—Abdominal pain—Etoposide—germ cell cancer	6.76e-05	0.000971	CcSEcCtD
Octreotide—Body temperature increased—Etoposide—germ cell cancer	6.76e-05	0.000971	CcSEcCtD
Octreotide—Tinnitus—Methotrexate—germ cell cancer	6.73e-05	0.000966	CcSEcCtD
Octreotide—Asthenia—Cisplatin—germ cell cancer	6.7e-05	0.000962	CcSEcCtD
Octreotide—Cardiac disorder—Methotrexate—germ cell cancer	6.7e-05	0.000961	CcSEcCtD
Octreotide—SSTR3—GPCR downstream signaling—AVP—germ cell cancer	6.67e-05	0.00466	CbGpPWpGaD
Octreotide—Immune system disorder—Methotrexate—germ cell cancer	6.52e-05	0.000936	CcSEcCtD
Octreotide—Nausea—Ifosfamide—germ cell cancer	6.43e-05	0.000924	CcSEcCtD
Octreotide—SSTR1—GPCR downstream signaling—AVP—germ cell cancer	6.4e-05	0.00447	CbGpPWpGaD
Octreotide—Diarrhoea—Cisplatin—germ cell cancer	6.39e-05	0.000918	CcSEcCtD
Octreotide—Alopecia—Methotrexate—germ cell cancer	6.37e-05	0.000915	CcSEcCtD
Octreotide—Mental disorder—Methotrexate—germ cell cancer	6.32e-05	0.000907	CcSEcCtD
Octreotide—Hypersensitivity—Etoposide—germ cell cancer	6.3e-05	0.000905	CcSEcCtD
Octreotide—Malnutrition—Methotrexate—germ cell cancer	6.28e-05	0.000902	CcSEcCtD
Octreotide—Erythema—Methotrexate—germ cell cancer	6.28e-05	0.000902	CcSEcCtD
Octreotide—Asthenia—Etoposide—germ cell cancer	6.14e-05	0.000881	CcSEcCtD
Octreotide—Back pain—Methotrexate—germ cell cancer	6.07e-05	0.000872	CcSEcCtD
Octreotide—SSTR3—Signaling by GPCR—AVP—germ cell cancer	6.06e-05	0.00424	CbGpPWpGaD
Octreotide—Pruritus—Etoposide—germ cell cancer	6.05e-05	0.000869	CcSEcCtD
Octreotide—Vomiting—Cisplatin—germ cell cancer	5.94e-05	0.000853	CcSEcCtD
Octreotide—Vision blurred—Methotrexate—germ cell cancer	5.92e-05	0.00085	CcSEcCtD
Octreotide—Rash—Cisplatin—germ cell cancer	5.89e-05	0.000846	CcSEcCtD
Octreotide—SSTR4—Signaling Pathways—FGF4—germ cell cancer	5.88e-05	0.00411	CbGpPWpGaD
Octreotide—Dermatitis—Cisplatin—germ cell cancer	5.88e-05	0.000845	CcSEcCtD
Octreotide—Diarrhoea—Etoposide—germ cell cancer	5.85e-05	0.000841	CcSEcCtD
Octreotide—Ill-defined disorder—Methotrexate—germ cell cancer	5.83e-05	0.000837	CcSEcCtD
Octreotide—SSTR1—Signaling by GPCR—AVP—germ cell cancer	5.81e-05	0.00406	CbGpPWpGaD
Octreotide—Anaemia—Methotrexate—germ cell cancer	5.8e-05	0.000833	CcSEcCtD
Octreotide—SSTR5—GPCR downstream signaling—AVP—germ cell cancer	5.67e-05	0.00397	CbGpPWpGaD
Octreotide—Malaise—Methotrexate—germ cell cancer	5.66e-05	0.000813	CcSEcCtD
Octreotide—Dizziness—Etoposide—germ cell cancer	5.66e-05	0.000812	CcSEcCtD
Octreotide—Vertigo—Methotrexate—germ cell cancer	5.64e-05	0.00081	CcSEcCtD
Octreotide—Nausea—Cisplatin—germ cell cancer	5.55e-05	0.000797	CcSEcCtD
Octreotide—Cough—Methotrexate—germ cell cancer	5.48e-05	0.000787	CcSEcCtD
Octreotide—Convulsion—Methotrexate—germ cell cancer	5.44e-05	0.000781	CcSEcCtD
Octreotide—Vomiting—Etoposide—germ cell cancer	5.44e-05	0.000781	CcSEcCtD
Octreotide—Rash—Etoposide—germ cell cancer	5.39e-05	0.000775	CcSEcCtD
Octreotide—Dermatitis—Etoposide—germ cell cancer	5.39e-05	0.000774	CcSEcCtD
Octreotide—Headache—Etoposide—germ cell cancer	5.36e-05	0.00077	CcSEcCtD
Octreotide—Arthralgia—Methotrexate—germ cell cancer	5.35e-05	0.000768	CcSEcCtD
Octreotide—Chest pain—Methotrexate—germ cell cancer	5.35e-05	0.000768	CcSEcCtD
Octreotide—Myalgia—Methotrexate—germ cell cancer	5.35e-05	0.000768	CcSEcCtD
Octreotide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—germ cell cancer	5.31e-05	0.000762	CcSEcCtD
Octreotide—Discomfort—Methotrexate—germ cell cancer	5.28e-05	0.000758	CcSEcCtD
Octreotide—SSTR4—Signaling Pathways—H2AFZ—germ cell cancer	5.25e-05	0.00367	CbGpPWpGaD
Octreotide—SSTR2—GPCR downstream signaling—AVP—germ cell cancer	5.24e-05	0.00366	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—OXT—germ cell cancer	5.22e-05	0.00365	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—AVP—germ cell cancer	5.15e-05	0.0036	CbGpPWpGaD
Octreotide—Anaphylactic shock—Methotrexate—germ cell cancer	5.13e-05	0.000736	CcSEcCtD
Octreotide—Infection—Methotrexate—germ cell cancer	5.09e-05	0.000731	CcSEcCtD
Octreotide—Nausea—Etoposide—germ cell cancer	5.08e-05	0.00073	CcSEcCtD
Octreotide—Nervous system disorder—Methotrexate—germ cell cancer	5.03e-05	0.000722	CcSEcCtD
Octreotide—Thrombocytopenia—Methotrexate—germ cell cancer	5.02e-05	0.000721	CcSEcCtD
Octreotide—SSTR1—Signaling Pathways—OXT—germ cell cancer	5.01e-05	0.0035	CbGpPWpGaD
Octreotide—Skin disorder—Methotrexate—germ cell cancer	4.98e-05	0.000715	CcSEcCtD
Octreotide—Hyperhidrosis—Methotrexate—germ cell cancer	4.95e-05	0.000711	CcSEcCtD
Octreotide—Anorexia—Methotrexate—germ cell cancer	4.89e-05	0.000701	CcSEcCtD
Octreotide—SSTR4—Signaling Pathways—KITLG—germ cell cancer	4.83e-05	0.00338	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—AVP—germ cell cancer	4.76e-05	0.00332	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—AVP—germ cell cancer	4.72e-05	0.0033	CbGpPWpGaD
Octreotide—Musculoskeletal discomfort—Methotrexate—germ cell cancer	4.67e-05	0.00067	CcSEcCtD
Octreotide—Insomnia—Methotrexate—germ cell cancer	4.64e-05	0.000666	CcSEcCtD
Octreotide—Paraesthesia—Methotrexate—germ cell cancer	4.6e-05	0.000661	CcSEcCtD
Octreotide—Dyspnoea—Methotrexate—germ cell cancer	4.57e-05	0.000656	CcSEcCtD
Octreotide—Somnolence—Methotrexate—germ cell cancer	4.56e-05	0.000654	CcSEcCtD
Octreotide—Dyspepsia—Methotrexate—germ cell cancer	4.51e-05	0.000648	CcSEcCtD
Octreotide—SSTR3—Signaling Pathways—FGF4—germ cell cancer	4.46e-05	0.00312	CbGpPWpGaD
Octreotide—Decreased appetite—Methotrexate—germ cell cancer	4.46e-05	0.00064	CcSEcCtD
Octreotide—SSTR5—Signaling Pathways—OXT—germ cell cancer	4.44e-05	0.0031	CbGpPWpGaD
Octreotide—Gastrointestinal disorder—Methotrexate—germ cell cancer	4.42e-05	0.000635	CcSEcCtD
Octreotide—Fatigue—Methotrexate—germ cell cancer	4.42e-05	0.000634	CcSEcCtD
Octreotide—Pain—Methotrexate—germ cell cancer	4.38e-05	0.000629	CcSEcCtD
Octreotide—SSTR1—Signaling Pathways—FGF4—germ cell cancer	4.27e-05	0.00299	CbGpPWpGaD
Octreotide—Feeling abnormal—Methotrexate—germ cell cancer	4.22e-05	0.000606	CcSEcCtD
Octreotide—Gastrointestinal pain—Methotrexate—germ cell cancer	4.19e-05	0.000602	CcSEcCtD
Octreotide—SSTR2—Signaling Pathways—OXT—germ cell cancer	4.1e-05	0.00286	CbGpPWpGaD
Octreotide—Urticaria—Methotrexate—germ cell cancer	4.07e-05	0.000585	CcSEcCtD
Octreotide—Body temperature increased—Methotrexate—germ cell cancer	4.05e-05	0.000582	CcSEcCtD
Octreotide—Abdominal pain—Methotrexate—germ cell cancer	4.05e-05	0.000582	CcSEcCtD
Octreotide—SSTR3—Signaling Pathways—H2AFZ—germ cell cancer	3.98e-05	0.00278	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—H2AFZ—germ cell cancer	3.82e-05	0.00267	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—FGF4—germ cell cancer	3.79e-05	0.00265	CbGpPWpGaD
Octreotide—Hypersensitivity—Methotrexate—germ cell cancer	3.78e-05	0.000542	CcSEcCtD
Octreotide—Asthenia—Methotrexate—germ cell cancer	3.68e-05	0.000528	CcSEcCtD
Octreotide—SSTR3—Signaling Pathways—KITLG—germ cell cancer	3.66e-05	0.00256	CbGpPWpGaD
Octreotide—Pruritus—Methotrexate—germ cell cancer	3.63e-05	0.000521	CcSEcCtD
Octreotide—SSTR4—Signaling Pathways—FGFR3—germ cell cancer	3.59e-05	0.00251	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—AVP—germ cell cancer	3.58e-05	0.0025	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—KITLG—germ cell cancer	3.51e-05	0.00245	CbGpPWpGaD
Octreotide—Diarrhoea—Methotrexate—germ cell cancer	3.51e-05	0.000504	CcSEcCtD
Octreotide—SSTR2—Signaling Pathways—FGF4—germ cell cancer	3.5e-05	0.00245	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—AVP—germ cell cancer	3.43e-05	0.0024	CbGpPWpGaD
Octreotide—Dizziness—Methotrexate—germ cell cancer	3.39e-05	0.000487	CcSEcCtD
Octreotide—SSTR5—Signaling Pathways—H2AFZ—germ cell cancer	3.39e-05	0.00237	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—KIT—germ cell cancer	3.3e-05	0.0023	CbGpPWpGaD
Octreotide—Vomiting—Methotrexate—germ cell cancer	3.26e-05	0.000468	CcSEcCtD
Octreotide—Rash—Methotrexate—germ cell cancer	3.23e-05	0.000464	CcSEcCtD
Octreotide—Dermatitis—Methotrexate—germ cell cancer	3.23e-05	0.000464	CcSEcCtD
Octreotide—Headache—Methotrexate—germ cell cancer	3.21e-05	0.000461	CcSEcCtD
Octreotide—SSTR2—Signaling Pathways—H2AFZ—germ cell cancer	3.12e-05	0.00218	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—KITLG—germ cell cancer	3.11e-05	0.00218	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—AVP—germ cell cancer	3.04e-05	0.00213	CbGpPWpGaD
Octreotide—Nausea—Methotrexate—germ cell cancer	3.04e-05	0.000437	CcSEcCtD
Octreotide—SSTR2—Signaling Pathways—KITLG—germ cell cancer	2.87e-05	0.00201	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—AVP—germ cell cancer	2.81e-05	0.00196	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—FGFR3—germ cell cancer	2.72e-05	0.0019	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—FGFR3—germ cell cancer	2.61e-05	0.00182	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—KIT—germ cell cancer	2.5e-05	0.00175	CbGpPWpGaD
Octreotide—SSTR4—Signaling by GPCR—HRAS—germ cell cancer	2.41e-05	0.00169	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—KIT—germ cell cancer	2.4e-05	0.00167	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—FGFR3—germ cell cancer	2.31e-05	0.00162	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—FGFR3—germ cell cancer	2.14e-05	0.00149	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—KIT—germ cell cancer	2.13e-05	0.00149	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—KIT—germ cell cancer	1.96e-05	0.00137	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—HRAS—germ cell cancer	1.83e-05	0.00128	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—MYC—germ cell cancer	1.81e-05	0.00127	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—HRAS—germ cell cancer	1.75e-05	0.00123	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—HRAS—germ cell cancer	1.55e-05	0.00109	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—TP53—germ cell cancer	1.49e-05	0.00104	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—HRAS—germ cell cancer	1.43e-05	0.001	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—HRAS—germ cell cancer	1.43e-05	0.000996	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—MYC—germ cell cancer	1.38e-05	0.000961	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—MYC—germ cell cancer	1.32e-05	0.000921	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—MYC—germ cell cancer	1.17e-05	0.000817	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—TP53—germ cell cancer	1.13e-05	0.000789	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—TP53—germ cell cancer	1.08e-05	0.000757	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—HRAS—germ cell cancer	1.08e-05	0.000755	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—MYC—germ cell cancer	1.08e-05	0.000754	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—HRAS—germ cell cancer	1.04e-05	0.000724	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—TP53—germ cell cancer	9.6e-06	0.000671	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—HRAS—germ cell cancer	9.18e-06	0.000642	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—TP53—germ cell cancer	8.86e-06	0.000619	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—HRAS—germ cell cancer	8.48e-06	0.000592	CbGpPWpGaD
